Purpose: Mobility impairments are a common consequence of stroke and spinal cord injury (SCI). Assistive products (APs) such as wheelchairs are often needed for activities and participation. The aim of the study was to explore the provision and use of APs in Germany and to identify associated factors underlying this practice.

Materials And Methods: Semi-structured interviews were conducted with 19 professionals from outpatient neurorehabilitation services (three general practitioners, five physical therapists, five occupational therapists, one speech therapist, one neuropsychologist, two outpatient nurses, one rehab technician and one social worker), two patient advocates (long-term survivors, each stroke and SCI) and 20 patients (10 each after stroke and SCI with mobility impairment, and first-ever affected). Analysis was performed by qualitative content analysis.

Results: Reported experiences were mixed, varying from high satisfaction to unusable APs and unmet needs. Identified factors associated with these experiences were related to care pathways, care coordination, inter-professional collaboration, professionals' knowledge and patient information, cost coverage, and approval procedures.

Conclusion: Overall, patients seem satisfied with the APs they receive, but patients with more severe mobility impairments in particular experience deficits in the provision and use of APs. Further research is needed to develop and test strategies for the provision and use of APs.

Download full-text PDF

Source
http://dx.doi.org/10.1080/17483107.2024.2348069DOI Listing

Publication Analysis

Top Keywords

provision aps
12
assistive products
8
patients stroke
8
stroke spinal
8
spinal cord
8
cord injury
8
mobility impairments
8
stroke sci
8
aps
6
provision
4

Similar Publications

Development of Priority Assistive Product Lists in Three African Countries.

Int J Environ Res Public Health

October 2024

Department of Rehabilitation Science and Technology, University of Pittsburgh, Pittsburgh, PA 15260, USA.

National Assistive Product Lists (APLs) play an important role in improving access to assistive products (APs). Assistive products are critical to enhancing the health, well-being, and quality of life of persons with disabilities and other functional limitations, including those associated with aging. Comparing national APL development across Malawi, Liberia, and Sierra Leone may provide insight into the differences between the resulting national APLs and how to enhance AP service delivery systems.

View Article and Find Full Text PDF

How might Hospital at Home enable a greener and healthier future?

NPJ Digit Med

September 2024

Else Kröner Fresenius Center for Digital Health, TUD Dresden University of Technology, Dresden, Germany.

Traditional healthcare delivery models face mounting pressure from rising costs, increasing demand, and a growing environmental footprint. Hospital at Home (HaH) has been proposed as a potential solution, offering care at home through in-person, virtual, or hybrid approaches. Despite focus on expanding HaH provision and capacity, research has primarily explored patient care outcomes, patient satisfaction economic costs with a key gap in its environmental impact.

View Article and Find Full Text PDF

Purpose: Mobility impairments are a common consequence of stroke and spinal cord injury (SCI). Assistive products (APs) such as wheelchairs are often needed for activities and participation. The aim of the study was to explore the provision and use of APs in Germany and to identify associated factors underlying this practice.

View Article and Find Full Text PDF

Development of a physical activity prescription course in a Doctor of Pharmacy program.

Adv Physiol Educ

June 2024

College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington, United States.

Pharmacists are increasingly becoming the healthcare professional who interacts most regularly with patients who have diseases or disorders for which exercise is an effective and recommended treatment. With the relative scarcity of clinical exercise physiologists in the United States, pharmacists are expected to provide lifestyle advice to their patients, especially in community (i.e.

View Article and Find Full Text PDF

The biological variation of serum 1,25-dihydroxyvitamin D and parathyroid hormone, and plasma fibroblast growth factor 23 in healthy individuals.

Clin Chim Acta

April 2024

Department of Clinical and Experimental Medicine, University Magna Grecia of Catanzaro, viale Europa, 88100 Catanzaro, Italy; Laboratory of Clinical Biochemistry, AOU "Renato Dulbecco" Hospital, 88100 Catanzaro, Italy. Electronic address:

Background And Aims: Measuring 1,25-dihydroxyvitamin D (1,25(OH)D), parathyroid hormone 1-84 (PTH 1-84) and intact FGF23 (iFGF23) is crucial for diagnosing a variety of diseases affecting bone and mineral homeostasis. Biological variability (BV) data are important for defining analytical quality specifications (APS), the usefulness of reference intervals, and the significance of variations in serial measurements in the same subject. The aim of this study was to pioneer the provision of BV estimates for 1,25(OH)2D and to improve existing BV estimates for iFGF23 and PTH 1-84.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!